Activation of Neu (ErbB-2) mediated by disulfide bond-induced dimerization reveals a receptor tyrosine kinase dimer interface

Molecular and Cellular Biology

Volumn 18, Issue 9, 1998, Pages 5371-7379

  Burke, Christine L ^a,b   Stern, David F ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID SUBSTITUTION; ARTICLE; DIMERIZATION; DISULFIDE BOND; ENZYME ACTIVITY; GENE MAPPING; HYPOTHESIS; PREDICTION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STOICHIOMETRY;

EID: 0031842104     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/mcb.18.9.5371     Document Type: Article

References (61)

1. Adams, P. D., D. M. Engelman, and A. T. Brunger. 1996. Improved prediction for the structure of the dimeric transmembrane domain of glycophorin A obtained through global searching. Proteins 26:257-261.
2. Akiyama, T., C. Sudo, H. Ogawara, K. Toyoshima, and T. Yamamoto. 1986. The product of the human c-erbB-2 gene: a 185-kilodalton glycoprotein with tyrosine kinase activity. Science 232:1644-1646.
3. Bargmann, C. I., M.-C. Hung, and R. A. Weinberg. 1986. Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185. Cell 45:649-657.
4. Bargmann, C. I., M. C. Hung, and R. A. Weinberg. 1986. The neu oncogene encodes an epidermal growth factor receptor-related protein. Nature 310: 226-230.
5. Bargmann, C. I., and R. A. Weinberg. 1988. Oncogenic activation of the neu-encoded receptor protein by point mutation and deletion. EMBO J. 7: 2043-2052.
6. Barlow, D., and J. Thornton. 1988. Helix geometry in proteins. J. Mol. Biol. 201:601-619.
7. Burke, C., and J. McMenamin-Balano. Unpublished data.
8. Burke, C. L., M. A. Lemmon, B. A. Coren, D. M. Engelman, and D. F. Stern. 1997. Dimerization of the p185neu transmembrane domain is necessary but not sufficient for transformation. Oncogene 14:687-696.
9. neu and p185neu. J. Biol. Chem. 267:20489-20492.
10. Cao, H., L. Bangalore, B. J. Bormann, and D. F. Stern. 1992. A subdomain in the transmembrane domain is necessary for p185neu*activation. EMBO J. 11:923-932.
11. neu. J. Biol. Chem. 267:20489-20492.
12. Cao, H., S. Decker, and D. F. Stern. 1991. TPA inhibits the tyrosine kinase activity of the neu protein in vivo and in vitro. Oncogene 6:705-711.
13. Chen, L. I., M. K. Webster, A. N. Meyer, and D. J. Donoghue. 1997. Transmembrane domain sequence requirements for activation of the p185c-neu receptor tyrosine kinase. J. Cell Biol. 137:619-631.
14. Chervitz, S. A., C. M. Lin, and J. J. Falke. 1995. Transmembrane signaling by the aspartate receptor: engineered disulfides reveal static regions of the subunit interface. Biochemistry 34:9722-9733.
15. Cochet, C., O. Kashles, E. M. Chambaz, I. Borello, C. R. King, and J. Schlessinger. 1988. Demonstration of epidermal growth factor-induced receptor dimerization in living cells using a chemical covalent cross-linking agent. J. Biol. Chem. 263:3290-3295.
16. Cohen, C., and D. A. D. Parry. 1990. Alpha-helical coiled-coils and bundles: how to design an alpha-helical protein. Proteins 7:1-15.
17. Coussens, L., T. L. Yang-Feng, Y.-C. Liao, E. Chen, A. Gray, J. McGrath, P. H. Seeburg, T. A. Libermann, J. Schlessinger, U. Francke, A. Levinson, and A. Ullrich. 1985. Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene. Science 230: 1132-1139.
18. Dankort, D. L., Z. Wang, V. Blackmore, M. F. Moran, and W. J. Muller. 1997. Distinct tyrosine autophosphorylation sites negatively and positively modulate Neu-mediated transformation. Mol. Cell. Biol. 17:5410-5425.
19. De Vos, A. M., M. Ultsch, and A. A. Kossiakoff. 1992. Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. Science 255:306-312.
20. Dougall, W. C., X. Qian, N. C. Peterson, M. J. Miller, A. Samanta, and M. I. Greene. 1994. The neu-oncogene: signal transduction pathways, transformation mechanisms and evolving therapies. Oncogene 9:2109-2123.
21. Downward, J., Y. Yarden, E. Mayes, G. Scrace, N. Totty, P. Stockwell, A. Ullrich, J. Schlessinger, and M. D. Waterfield. 1984. Close similarity of epidermal growth factor receptor and v-erbB oncogene protein sequences. Nature 307:521-527.
22. Drebin, J. A., D. F. Stern, V. C. Link, R. A. Weinberg, and M. I. Greene. 1984. Monoclonal antibodies recognize a cell-surface antigen associated with an activated cellular oncogene. Nature 312:545-548.
23. Garnier, N., D. Genest, J. P. Duneau, and M. Genest. 1997. Molecular modeling of c-erbB2 receptor dimerization: coiled-coil structure of wild and oncogenic transmembrane domains - stabilization by interhelical hydrogen bonds in the oncogenic form. Biopoly 42:157-168.
24. Giordiano, S., M. F. Di Renzo, R. P. Narsimahan, C. S. Cooper, C. Rosa, and P. M. Comoglio. 1989. Biosynthesis of the protein encoded by the c-met proto-oncogene. Oncogene 4:1383-1388.
25. Guan, J.-L., and J. K. Rose. 1984. Conversion of a secretory protein into a transmembrane protein results in its transport to the Golgi complex but not the cell surface. Cell 37:779-787.
26. Guy, C. T., M. A. Webster, M. Schaller, T. J. Parsons, R. D. Cardiff, and W. J. Muller. 1992. Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. Proc. Natl. Acad. Sci. USA 89:10578-10582.
27. Heldin, C.-H., and A. Ostman. 1996. Ligand-induced dimerization of growth factor receptors: variations on the theme. Cytokine Growth Factor Rev. 7: 33-40.
28. Heldin, C. H. 1995. Dimerization of cell surface receptors in signal transduction. Cell 80:213-223.
29. Hynes, N. E., and D. F. Stern. 1994. The biology of erbB-2/neu/HER-2 and its role in cancer. Biochim. Biophys. Acta Rev. Cancer 1198:165-184.
30. Kamps, M. P., and B. M. Sefton. 1988. Identification of multiple novel polypeptide substrates of the v-src, v-yes, v-fps, v-ros, and v-erb-B oncogenic tyrosine protein kinases utilizing antisera against phosphotyrosine. Oncogene 2:305-315.
31. Kokai, Y., J. N. Meyers, T. Wada, V. I. Brown, C. M. LeVea, J. G. Davis, K. Dobashi, and M. I. Greene. 1989. Synergistic interaction of p185 c-neu and the EGF receptor leads to transformation of rodent fibroblasts. Cell 58:287-292.
32. Lemmon, M. A., Z. Bu, J. E. Ladbury, M. Zhou, D. Pinchasi, I. Lax, D. Engelman, and J. Schlessinger. 1997. Two EGF molecules contribute additively to stabilization of the EGFR dimer. EMBO J. 16:281-294.
33. Lemmon, M. A., and D. M. Engelman. 1992. Helix-helix interactions inside lipid bilayers. Curr. Opin. Struct. Biol. 2:511-518.
34. Lemmon, M. A., J. M. Flanagan, J. F. Hunt, B. D. Adair, B.-J. Bormann, C. E. Dempsey, and D. M. Engelman. 1992. Glycophorin A dimerization is driven by specific interactions between transmembrane α-helices. J. Biol. Chem. 267:7683-7689.
35. Lofts, F. J., H. C. Hurst, M. J. E. Sternberg, and W. J. Gullick. 1993. Specific short transmembrane sequences can inhibit transformation by the mutant neu growth factor receptor in vitro and in vivo. Oncogene 8:2813-2820.
36. Lynch, B. A., and D. E. Koshland. 1991. Disulfide cross-linking studies of the transmembrane regions of the aspartate sensory receptor of Escherichia coli. Proc. Natl. Acad. Sci. USA 88:10402-10406.
37. MacKenzie, K. R., J. H. Prestegard, and D. M. Engelman. 1997. A transmembrane helix dimer: structure and implications. Science 276:131-133.
38. Martin-Zanca, D., S. H. Hughes, and M. Barbacid. 1986. A human oncogene formed by the fusion of truncated tropomyosin and protein-tyrosine kinase sequences. Nature 319:743-748.
39. Matsushime, H., L.-H. Wang, and M. Shibuya. 1986. Human c-ros-1 gene homologous to the v-ros sequence of UR2 sarcoma virus encodes for a transmembrane receptor-like molecule. Mol. Cell. Biol. 6:3000-3004.
40. Redemann, N., B. Holzmann, T. von Ruden, E. F. Wagner, J. Schlessinger, and A. Ullrich. 1992. Antioncogenic activity of signalling-defective epidermal growth factor receptor mutants. Mol. Cell. Biol. 12:491-498.
41. Riese, D. J., II, and D. F. Stern. 1998. Specificity within the EGF/ErbB receptor family signaling network. Bioessays 20:41-48.
42. Roseman, M. A. 1988. Hydropathy of polar amino acid side-chains is markedly reduced by flanking peptide bonds. Mol. Biol. 200:513-522.
43. Schlessinger, J. 1988. Signal transduction by allosteric receptor oligomerization. Trends Biochem. Sci. 13:443-447.
44. Siegel, P. M., D. L. Dankort, W. R. Hardy, and W. J. Muller. 1994. Novel activating mutations in the neu proto-oncogene involved in induction of mammary tumors. Mol. Cell. Biol. 14:7068-7077.
45. Siegel, P. M., and W. J. Muller. 1996. Mutations affecting conserved cysteine residues within the extracellular domain of Neu promote receptor dimerization and activation. Proc. Natl. Acad. Sci. USA 93:8878-8883.
46. Smith, S. O., C. S. Smith, and B. J. Bormann. 1996. Strong hydrogen bonding interactions involving a buried glutamic acid in the transmembrane sequence of the neu/erbB-2 receptor. Nat. Struct. Biol. 3:252-258.
47. Sorokin, A., M. A. Lemmon, A. Ullrich, and J. Schlessinger. 1994. Stabilization of an active dimeric form of the epidermal growth factor receptor by introduction of an inter-receptor disulfide bond. J. Biol. Chem. 269:9752-9759.
48. Stern, D. F., P. A. Heffernan, and R. A. Weinberg. 1986. p185, a product of the neu proto-oncogene, is a receptorlike protein associated with tyrosine kinase activity. Mol. Cell. Biol. 6:1729-1740.
49. neu: a potential model for receptor interactions. EMBO J. 7: 995-1001.
50. neu stimulates tyrosine phosphorylation in vivo. Mol. Cell. Biol. 8:3969-3973.
51. Sternberg, M. J. E., and W. J. Gullick. 1989. Neu receptor dimerization. Nature 339:587.
52. Takahshi, M., and G. M. Cooper. 1987. ret transforming gene encodes a fusion protein homologous to tyrosine kinases. J. Biol. Chem. 263:3400-3447.
53. Tzahar, E., R. Pinkas-Kramarski, J. D. Moyer, L. N. Klapper, I. Alroy, G. Levkowitz, M. Shelly, S. Henis, M. Eisenstein, B. J. Ratzkin, M. Sela, G. C. Andrews, and Y. Yarden. 1997. Bivalence of EGF-like ligands drives the ErbB signaling network. EMBO J 16:4938-4950.
54. Watowich, S. S., D. J. Hilton, and H. P. Lodish. 1994. Activation and inhibition of erythropoietin receptor function: role of receptor dimerization. Mol. Cell. Biol. 14:3535-3549.
55. Weiner, D. B., J. Liu, J. A. Cohen, W. V. Williams, and M. I. Greene. 1989. A point mutation in the neu oncogene mimics ligand induction of receptor aggregation. Nature 339:230-231.
56. Wiesmann, C., G. Fuh, H. W. Christinger, C. Eigenbrot, J. A. Wells, and A. M. deVos. 1997. Crystal structure at 1.7Å resolution of VEGF in complex with domain 2 of the Flt-1 receptor. Cell 91:695-704.
57. Yamamoto. T., S. Ikawa, T. Akiyama, K. Semba, N. No mura, N. Miyajima, T. Saito, and K. Toyoshima. 1986. Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor. Nature 319:230-234.
58. Yarden, Y. 1990. Agonistic antibodies stimulate the kinase encoded by the neu protooncogene in living cells but the oncogenic mutant is constitutively active. Proc. Natl. Acad. Sci. USA 87:2569-2573.
59. Yarden, Y., and J. Schlessinger. 1987. Epidermal growth factor induces rapid, reversible aggregation of the purified epidermal growth factor receptor. Biochemistry 26:1443-1451.
60. Yarden, Y., and J. Schlessinger. 1987. Self- phosphorylation of epidermal growth factor receptor: evidence for a model of intermolecular allosteric activation. Biochemistry 26:1434-1442.
61. Yun, R. H., A. Anderson, and J. Hermans. 1991. Proline in α-helix: stability and conformation studied by dynamics stimulation. Proteins 10:219-228.